Le Lézard2h
Nova Scotia shows leadership in publicly reimbursing Pluvictotm for eligible patients with advanced prostate cancer
Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvictotm (lutetium (177Lu) vipivotide tetraxetan ...
Nova Scotia shows leadership in publicly reimbursing Pluvicto™ for eligible patients with advanced prostate cancer
Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan injection), providing ...
Cure Today4h
Cabometyx Demonstrates PFS Benefit Versus Placebo in GI-NETs
Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...
Le Lézard2h
Joint Statement - New oyster movement rules in Prince Edward Island to help prevent further spread of MSX
Prince Edward Island (PEI) first detected multinucleate sphere unknown (MSX) ? an oyster disease caused by the Haplosporidium nelsoni parasite. Since that time, the Canadian Food Inspection Agency ...
snmjournals.org4h
From Scientist to Analyst to Strategist
Ken Herrmann, MD, MBA, from the Universitätsklinikum Essen (Germany), and Johannes Czernin, MD, from the David Geffen School ...